Glioblastoma Stem-Like Cells, Metabolic Strategy to Kill a Challenging Target
Over the years, substantial evidence has definitively confirmed the existence of cancer stem-like cells within tumors such as Glioblastoma (GBM). The importance of Glioblastoma stem-like cells (GSCs) in tumor progression and relapse clearly highlights that cancer eradication requires killing of GSCs...
Main Authors: | Delphine Garnier, Ophélie Renoult, Marie-Clotilde Alves-Guerra, François Paris, Claire Pecqueur |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.00118/full |
Similar Items
-
Decipher the Glioblastoma Microenvironment: The First Milestone for New Groundbreaking Therapeutic Strategies
by: Giuseppe Nicolò Fanelli, et al.
Published: (2021-03-01) -
Immunotherapy for Glioblastoma: Current Progress and Challenges
by: Miranda W. Yu, et al.
Published: (2021-05-01) -
Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges
by: Frontiers Production Office
Published: (2021-10-01) -
Altered lipid metabolism marks glioblastoma stem and non-stem cells in separate tumor niches
by: Sajina Shakya, et al.
Published: (2021-05-01) -
Macrophages and microglia: the cerberus of glioblastoma
by: Alice Buonfiglioli, et al.
Published: (2021-03-01)